Companies

Hvivo to make return to shareholders from strong 2022 results

Pharmaceutical services company expects full-year revenues of £50.6 million for 2022, a 30 per cent increase year-on-year

Cathal Friel, chairman and co-founder of Poolbeg Pharma: the serial entrepreneur said he would like to do one initial public offering every year.Picture: Fergal Phillips

Hvivo, the Dublin-listed pharmaceutical services company founded by Cathal Friel, has said it will make a return to shareholders in respect of the company’s performance last year.

The company expects to report record full year revenues of £50.6 million for 2022, a 30 per cent increase year-on-year. The details of the return to shareholders will be announced alongside the publication of the group's audited results for 2022 in April.

“The distribution reflects the group's exceptional ...